75 138

Cited 0 times in

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity

Authors
 Min Young Chun  ;  Hyemin Jang  ;  Hee Jin Kim  ;  Jun Pyo Kim  ;  John Gallacher  ;  José Antonio Allué  ;  Leticia Sarasa  ;  Sergio Castillo  ;  María Pascual-Lucas  ;  Duk L Na  ;  Sang Won Seo 
Citation
 FRONTIERS IN AGING NEUROSCIENCE, Vol.15 : 1126799, 2023-03 
Journal Title
FRONTIERS IN AGING NEUROSCIENCE
Issue Date
2023-03
Keywords
Alzheimer’s disease ; apolipoprotein E ; cerebrospinal fluid ; plasma ; positron emission tomography ; β-Amyloid
Abstract
Background : Early detection of β-amyloid (Aβ) accumulation, a major biomarker for Alzheimer’s disease (AD), has become important. As fluid biomarkers, the accuracy of cerebrospinal fluid (CSF) Aβ for predicting Aβ deposition on positron emission tomography (PET) has been extensively studied, and the development of plasma Aβ is beginning to receive increased attention recently. In the present study, we aimed to determine whether APOE genotypes, age, and cognitive status increase the predictive performance of plasma Aβ and CSF Aβ levels for Aβ PET positivity.
Methods : We recruited 488 participants who underwent both plasma Aβ and Aβ PET studies (Cohort 1) and 217 participants who underwent both cerebrospinal fluid (CSF) Aβ and Aβ PET studies (Cohort 2). Plasma and CSF samples were analyzed using ABtest-MS, an antibody-free liquid chromatography-differential mobility spectrometry-triple quadrupole mass spectrometry method and INNOTEST enzyme-linked immunosorbent assay kits, respectively. To evaluate the predictive performance of plasma Aβ and CSF Aβ, respectively, logistic regression and receiver operating characteristic analyses were performed.
Results : When predicting Aβ PET status, both plasma Aβ42/40 ratio and CSF Aβ42 showed high accuracy (plasma Aβ area under the curve (AUC) 0.814; CSF Aβ AUC 0.848). In the plasma Aβ models, the AUC values were higher than plasma Aβ alone model, when the models were combined with either cognitive stage (p < 0.001) or APOE genotype (p = 0.011). On the other hand, there was no difference between the CSF Aβ models, when these variables were added.
Conclusion : Plasma Aβ might be a useful predictor of Aβ deposition on PET status as much as CSF Aβ, particularly when considered with clinical information such as APOE genotype and cognitive stage.
Files in This Item:
T202302857.pdf Download
DOI
10.3389/fnagi.2023.1126799
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurology (신경과학교실) > 1. Journal Papers
Yonsei Authors
Chun, Min Young(전민영)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194280
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links